Association of the tetraspan protein CD9 with integrins on the surface of S-16 Schwann cells

Journal of Neurochemistry

Volumn 67, Issue 6, 1996, Pages 2505-2513

  Hadjiargyrou, Michael ^a,b   Kaprielian, Zaven ^a,c   Kato, Nobuo ^a,d   Patterson, Paul H ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d Kyoto University   (Japan)

Author keywords

CD9 protein; Integrins; Schwann cells; Target of an antiproliferative antibody TAPA 1; Tetraspan proteins

Indexed keywords

CD9 ANTIGEN; INTEGRIN;

ANIMAL CELL; ARTICLE; IMMUNOPRECIPITATION; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; SCHWANN CELL;

ANIMALIA;

EID: 0029805118     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67062505.x     Document Type: Article

References (61)

1. Akeson R. and Warren S. L. (1984) Detection of a cell surface antigen found on rat peripheral nervous system neurons and multiple glia: astrocytes, oligodendrocytes, and Schwann cells. J. Neurosci. Res. 12, 41-57.
2. Angelisova P., Hilgert I., and Horejsi V. (1994) Association of four antigens of the tetraspan family (CD37, CD53, TAPA-1, and R2/C33) with MHC class II glycoproteins. Immunogenetics 39, 249-256.
3. Anton E. S., Hadjiargyrou M., Patterson P. H., and Matthew W. D. (1995) CD9 plays a role in Schwann cell migration in vitro. J. Neurosci. 15, 584-595.
4. 6. J. Cell. Physiol. 125, 420-426.
5. Banerjee S. A. and Patterson P. H. (1995) Schwann cell CD9 expression is regulated by axons. Mol. Cell. Neurosci. 6, 462-473.
6. Bartolazzi A., Cerboni C., Nicotra M. R., Mottolese M., Bigotti A., and Natali P. G. (1994) Transformation and tumor progression are frequently associated with expression of the α3/β1 heterodimer in solid tumors. Int. J. Cancer 58, 488-491.
7. Bartolazzi A., Cerboni C., Flamini G., Bigotti A., Lauriola L., and Natali P. G. (1995) Expression of the α3/β1 integrin receptor and its ligands in human lung tumors. Int. J. Cancer 64, 248-252.
8. Berditchevski F., Zutter M. M., and Hemler M. E. (1996) Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins). Mol. Biol. Cell 7, 193-207.
9. Bossy B. and Reichardt L. F. (1990) Chick integrin αV subunit molecular analysis reveals high conservation of structural domains and association with multiple β subunits in embryo fibroblasts. Biochemistry 29, 10191-10198.
10. Bossy B., Bossy-Wetzel E., and Reichardt L. F. (1991) Characterization of the integrin α8 subunit: a new integrin β-associated subunit, which is prominently expressed on axons and on cells in contact with basal laminae in chick embryos. EMBO J. 10, 2375-2385.
11. Boucheix C. and Benoit P. (1988) CD9 antigen: will platelet physiology help to explain the function of a surface molecule during hematopoietic differentiation? Nouv. Rev, Fr. Hematol. 30, 201-202.
12. 6Fab. FEBS Lett. 161, 289-295.
13. Boucheix C., Benoit P., Krief P., Billard M., Mishal Z., Azzarone B., Rendu E., Esnouf J., Bredoux R., Levy-Toledano S., Soria C., Perrot J. Y., Mirshahi M., Giannoni F., Bernadou A., and Soria J. (1987) Platelet aggregation Induced by CD9 mAbs. Mechanisms and comparisons with platelet aggregating properties of mAbs directed against other membrane antigens, in Platelet Aggregation Induced by CD9 mAbs. Mechanisms and Comparisons with Platelet Aggregating Properties of mAbs Directed Against Other Membrane Antigens (McMichael A. J., ed), pp. 780-782. Oxford University Press, Oxford.
14. Boucheix C., Benoit P., Frachet P., Billard M., Worthington R. E., Gagnon J., and Uzan G. (1991) Molecular cloning of the CD9 antigen. J. Biol. Chem. 266, 117-122.
15. Chandler C. E., Parsons L. M., Hosang M., and Shooter E. M. (1984) A monoclonal antibody modulates the interaction of nerve growth factor with PC12 cells. J. Biol. Chem. 259, 6882-6889.
16. de Curtis I. and Reichardt L. F. (1993) Function and spatial distribution in developing chick retina of the laminin receptor α6β1 and its isoforms. Development 118, 377-388.
17. Dedhar S. and Saulnier R. (1990) Alterations in integrin receptor expression on chemically transformed human cells: specific enhancement of laminin and collagen receptor complexes. J. Cell Biol. 110, 481-489.
18. Fearon D. T. and Carter R. H. (1995) The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Anna. Rev. Immimol. 13, 127-149.
19. Forsyth K. D. (1991) Anti-CD9 antibodies augment neutrophil adherence to endothelium. Immunology 72, 292-296.
20. Goda S., Hammer J., Kobiler D., and Quarles R. H. (1991) Expression of the myelin-associated glycoprotein in cultures of immortalized Schwann cells. J. Neurochem. 56, 1354-1361.
21. Griffith L., Slupsky J., Seehafer J., Boshkov L., and Shaw A. R. E. (1991) Platelet activation by immobilized monoclonal antibody: evidence for a CD9 proximal signal. Blood 78, 1753-1759.
22. Hadjiargyrou M. and Patterson P. H. (1995) An anti-CD9 monoclonal antibody promotes adhesion and induces proliferation of Schwann cells in vitro. J. Neurosci. 15, 574-583.
23. Higashihara M., Maeda H., Shibata Y., Kume S., and Ohashi T. (1985) A monoclonal anti-human platelet antibody: a new platelet aggregating substance. Blood 65, 382-391.
24. Higashiyama M., Taki T., Ieki Y., Adachi M., Huang C-L., Koh T., Kodama K., Doi O., and Miyake M. (1995) Reduced motility related protein (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer. Cancer Res. 55, 6040-6044.
25. Ikeyama S., Koyama M., Yamaoko M., Sasada R., and Miyake M. (1993) Suppression of cell motility and metastasis by transfection with human motility-relaled protein (MRP-1/CD9) DNA. J. Exp. Med. 177, 1231-1237.
26. Imai T., Kakizaki M., Nishimura M., and Yoshie O. (1995) Molecular analysis of the association of CD4 with two members of the transmembrane 4 superfamily, CD81 and CD82. J. Immunol. 155, 1229-1239.
27. Jennings L. K., Fox C. F., Kouns W. C., McKay C. P., Ballou L. R., and Schultz H. E. (1990) The activation of human platelets mediated by anti-human platelet p24/CD9 monoclonal antibodies. J. Biol. Chem. 265, 3815-3822.
28. Jones N. H., Borowitz M. J., and Metzgar R. S. (1982) Characterization and distribution of a 24,000-molecular weight antigen defined by a monoclonal antibody (DU-ALL-I) elicited to common acute lymphoblastic leukemia (cALL) cells. Leuk. Res. 6, 449-460.
29. Kaprielian Z. and Patterson P. H. (1993) Surface and cytoskeletal markers of rostrocaudal position in the mammalian nervous system. J. Neurosci. 13, 2495-2508.
30. Kaprielian Z., Cho K.-O., Hadjiargyrou M., and Patterson P. H. (1995) CD9, a major platelet cell surface glycoprotein, is a ROCA antigen and is expressed in the nervous system. J. Neurosci. 15, 562-573.
31. Kemshead J. T., Fritschy J., Asser U., Sutherland R., and Greaves M. F. (1982) Monoclonal antibodies defining markers with apparent selectivity for particular haematopoietic cell types may also detect antigens on cells of neural crest origin. Hybridoma 1, 109-123.
32. Kersey J. S., Lebien T., Abramson C. S., Sutherland R., and Greaves M. F. (1981) p24: a human leukemia associated and lymphohematopoietic progenitor cell surface structure identified with monoclonal antibody. J. Exp. Med. 153, 726-731.
33. Komada Y., Peiper S. C., Melvin S. L., Metzgar W. D., Tarnowski B. H., and Green A. A. (1983) A monoclonal antibody (SJ-9A4) to p24 present on alls, neuroblastomas and platelets. I. Characterization and development of a unique radioimmunometric assay. Leuk. Res. 7, 487-498.
34. Lanza F., Wolf D., Fox C. F., Kieffer N., Seyer J. M., Fried V. A., Coughlin S. R., Phillips D. R., and Jennings L. K. (1991)cDNA cloning and expression of platelet p24/CD9. J. Biol. Chem. 266, 10638-10645.
35. Letarte M., Seehafer J. G., Greaves A., Masellis-Smith A., and Shaw A. R. E. (1993) Homotypic aggregation of pre-B leukemic cell lines by antibodies to VLA integrins correlates with their expression of CD9. Leukemia 7, 93-103.
36. Lin C. S., Zhang K., and Kramer R. (1993) α6 integrin is upregulated in step increments accompanying neoplastic transformation and tumorigenic conversion of human fibroblasts. Cancer Res. 53, 2950-2953.
37. Martin-Alonso J.-M., Hemando N., Ghosh S., and Coca-Prados M. (1992) Molecular cloning of the bovine CD9 antigen from ocular ciliary epithelial cells. J. Biochem. (Tokyo) 112, 63-67.
38. Masselis-Smith A. and Shaw A. R. E. (1994) CD9-regulated adhesion. Anti-CD9 monoclonal antibody induces pre-B cell adhesion to bone marrow fibroblasts through de novo recognition of fibronectin. J. Immunol. 152, 2768-2777.
39. Masselis-Smith A., Jensen G. S., Seehafer J. G., Slupsky J. R., and Shaw A. R. E. (1990) Anti-CD9 monoclonal antibodies induce homotypic adhesion of pre-B cell lines by a novel mechanism. J. Immunol. 144, 1607-1613.
40. Miller J. L., Kupinski J. M., and Hustad K. O. (1986) Characterization of a platelet membrane protein of low molecular weight associated with platelet activation following binding by monoclonal antibody AG-1. Blood 68, 743-751.
41. Mitamura T., Iwamoto R., Umata T., Tomo Y., Urabe I., Tsuneoka M., and Mekada E. (1992) The 27-kDa diphtheria toxin receptor-associated protein (DRAP27) from Verocells is the monkey homologue of human CD9 antigen: expression of DRAP27 elevates the number of diphtheria toxin receptors on toxin-sensitive cells. J. Cell Biol. 118, 1389-1399.
42. Miyake M., Koyama M., Seno M., and Ikeyama S. (1991) Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility. J. Exp. Med. 174, 1347-1354.
43. Miyake M., Nakano K., Ieki Y., Adachi M., Huang C.-L., Itoi S.-I., Koh T., and Taki T. (1995) Motility related protein 1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer. Cancer Res. 55, 4127-4131.
44. Nakamura K., Iwamoto R., and Mekada E. (1995) Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 forms a complex with integrin α3β1 at cell-cell contacts. J. Cell Biol. 129, 1691-1705.
45. Natali P. G., Nicotra M. R., Bartolazzi A., Cavaliere R., and Bigotti A. (1993) Integrin expression in cutaneous malignant association of the α3/β1 heterodimer with tumor progression. Int. J. Cancer 54, 68-72.
46. Oren R., Takahashi S., Doss C., Levy R., and Levy S. (1990) TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol. Cell. Biol. 10, 4007-4015.
47. syk in human platelets. J. Biol. Chem. 270, 15119-15124.
48. Rubinstein E., Billard M., Plaisance S., Prenant M., and Boucheix C. (1993) Molecular cloning of the mouse equivalent of CD9 antigen. Thromb. Res. 71, 377-383.
49. Rubinstein E., Le Naour F., Billard M., Prenant M., and Boucheix C. (1994) CD9 antigen is an accessory subunit of the VLA integrin complexes. Eur. J. Immunol. 24, 3005-3013.
50. Schmidt C., Kunemund V., Wintergerst E. S., Schmitz B., and Schachner M. (1996) CD9 of mouse brain is implicated in neunte outgrowth and cell migration in vitro and is associated with the α6/β1 integrin and the neural adhesion molecule L1. J. Neurosci. Res. 43, 12-31.
51. Seehafer J. G. and Shaw A. R. E. (1991) Evidence that the signal-initiating membrane protein CD9 is associated with small GTP-binding proteins. Biochem. Biophys. Res. Commun. 179, 401-406.
52. Shaw A. R. E., Domanska A., Mak A., Gilchrist A., Dobler K., Visser L., Poppema S., Fliegel L., Letarte M., and Willett B. J. (1995) Ectopic expression of human and feline CD9 in a human B cell line confers β1 integrin-dependent motility on fibronectin and laminin substrates and enhanced tyrosine phosphorylation. J. Biol. Chem. 41, 24092-24099.
53. Si Z. and Hershey P. (1993) Expression of the neuroglandular antigen and analogues in melanoma. CD9 expression appears inversely related to metastatic potential of melanoma. Int. J. Cancer 54, 37-43.
54. Slupsky J. R., Seehafer J. G., Tang S.-C., Masselis-Smith A., and Shaw A. R. E. (1989) Evidence that monoclonal antibodies against CD9 antigen induce specific association between CD9 and the platelet glycoprotein IIb-IIIa complex. J. Biol. Chem. 264, 12289-12293.
55. Tole S. and Patterson P. H. (1993) Distribution of CD9 in the developing and mature rat nervous system. Dev. Dynamics 197, 94-106.
56. Tomasselli K. J., Damsky C. H., and Reichardt L. F. (1988) Purification and characterization of mammalian integrins expressed by a rat neuronal cell line (PC12): evidence that they function as αlβ heterodimeric receptors for laminin and type IV collagen. J. Cell Biol. 107, 1241-1252.
57. Tomasselli K. J., Hall D. E., Flier L. A., Gehlsen K. R., Turner D. C., Carbonetto S., and Reichardt L. F. (1990) A neuronal cell line (PC 12) expresses two β1-class integrins - α1β1 and α3/β1 - that recognize different neurite outgrowth-promoting domains in laminin. Neuron 5, 651-662.
58. Von dem Borne A. E. G. K., Modderman P. W., Admiraal L. G., and Nieuwenhuis H. K. (1989) Platelet antibodies, the overall results, in Platelet Antibodies, the Overall Results (Knapp W., Dorken B., Gilks W. R., Rieber E. P., Schmidt R. E., Stein H., and Von dem Borne A. E. G. K., eds), pp. 951-960. Oxford University Press. Oxford.
59. Willet B. J. and Neil J. C. (1995) cDNA cloning and eukaryotic expression of feline CD9. Mol. Immunol. 32, 417-423.
60. Wright M. D. and Tomlinson M. G. (1994) The ins and outs of the transmembrane 4 superfamily. Immunol. Today 15, 558-594.
61. Yatomi Y., Ozaki Y., Satoh K., and Kume S. (1993) Anti-CD9 monoclonal antibody elicits staurosporine inhibitable phosphatidylinositol 4,5-biphosphate hydrolysis, phosphatidylinositol 3,4-biphosphate synthesis, and protein-tyrosine phosphorylation in human platelets. FEBS Lett. 322, 285-290.